UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004305
Receipt number R000005159
Scientific Title Evaluation for neurotoxicity of oxaliplatin using Nerve Conduction Velocity
Date of disclosure of the study information 2010/09/30
Last modified on 2013/04/02 21:23:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation for neurotoxicity of oxaliplatin using Nerve Conduction Velocity

Acronym

NEO-NCV study

Scientific Title

Evaluation for neurotoxicity of oxaliplatin using Nerve Conduction Velocity

Scientific Title:Acronym

NEO-NCV study

Region

Japan


Condition

Condition

colorectal cancer

Classification by specialty

Gastroenterology Neurology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the utility of nerve conduction velocity (NCV) and tuning fork for the oxaliplatin induced neurotoxicity

Basic objectives2

Others

Basic objectives -Others

To evaluate the utility of nerve conduction velocity (NCV) and tuning fork for the oxaliplatin induced neurotoxicity

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. Collation between NCV and oxaliplatin induced neurotoxicity
2. Collation between tuning fork and oxaliplatin induced neurotoxicity
3. Analyze the mechanism of oxaliplatin induced neurotoxicity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

1.Nerve Conduction Velocity
2.tuning fork

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Histologically confirmed colorectal cancer
2) No prior L-OHP administration
3) No peripheral neuropathy
4) Voluntary written informed consent

Key exclusion criteria

Metastasis to the CNS

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshinori Hirashima

Organization

Oita University, Faculty of Medecine

Division name

Medical Oncology

Zip code


Address

1-1 Idaigaoka, Hasama-machi, Yufu-city, Oita 879-5593, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Oita University, Faculty of Medecine

Division name

Medical Oncology

Zip code


Address


TEL


Homepage URL


Email

hira@oita-u.ac.jp


Sponsor or person

Institute

Oita University, Faculty of Medecine

Institute

Department

Personal name



Funding Source

Organization

Oita University, Faculty of Medecine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 09 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2008 Year 12 Month 01 Day

Last follow-up date

2013 Year 03 Month 01 Day

Date of closure to data entry

2013 Year 03 Month 01 Day

Date trial data considered complete

2013 Year 03 Month 01 Day

Date analysis concluded

2013 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 09 Month 30 Day

Last modified on

2013 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005159


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name